Financhill
Sell
20

ADAP Quote, Financials, Valuation and Earnings

Last price:
$0.60
Seasonality move :
36.97%
Day range:
$0.59 - $0.61
52-week range:
$0.47 - $2.05
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.85x
P/B ratio:
1.93x
Volume:
3.1M
Avg. volume:
2.7M
1-year change:
37.05%
Market cap:
$154.8M
Revenue:
$60.3M
EPS (TTM):
-$0.18
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $1.1M $4M $6.1M $27.1M $60.3M
Revenue Growth (YoY) -98.11% 252.76% 55.36% 341.5% 122.05%
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $97.5M $91.6M $111.1M $127.7M $126.5M
Selling, General & Admin $43.4M $45.8M $57.3M $61.1M $71.8M
Other Inc / (Exp) $75K $1.2M $3.9M -$2.8M $19.5M
Operating Expenses $140.9M $137.4M $168.4M $188.8M $198.3M
Operating Income -$139.8M -$133.4M -$162.2M -$161.7M -$138M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$136.9M -$129.9M -$157.3M -$163M -$112.5M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $242K $162K $791K $2.5M $1.3M
Net Income to Company -$137.2M -$130.1M -$158.1M -$165.5M -$113.9M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$137.2M -$130.1M -$158.1M -$165.5M -$113.9M
 
Basic EPS (Cont. Ops) -$1.32 -$0.90 -$1.02 -$1.02 -$0.54
Diluted EPS (Cont. Ops) -$1.32 -$0.90 -$1.02 -$1.02 -$0.54
Weighted Average Basic Share $105M $142.5M $155.8M $161.2M $201.1M
Weighted Average Diluted Share $105M $142.5M $155.8M $161.2M $201.1M
 
EBITDA -$131.8M -$125.8M -$155.7M -$155.6M -$128.2M
EBIT -$139.8M -$133.4M -$162.2M -$161.7M -$138M
 
Revenue (Reported) $1.1M $4M $6.1M $27.1M $60.3M
Operating Income (Reported) -$139.8M -$133.4M -$162.2M -$161.7M -$138M
Operating Income (Adjusted) -$139.8M -$133.4M -$162.2M -$161.7M -$138M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $1.2M $1.2M $7M $7.3M $40.9M
Revenue Growth (YoY) 403.38% 0.84% 482.46% 4.45% 458.83%
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $24.1M $28.2M $33.2M $37.8M $34.3M
Selling, General & Admin $13M $15.2M $16.8M $16.2M $21.3M
Other Inc / (Exp) -$1.7M -$237K $1.6M -$430K -$3.1M
Operating Expenses $37.1M $43.4M $50M $54M $55.6M
Operating Income -$35.9M -$42.2M -$43M -$46.6M -$14.7M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$35.4M -$42.2M -$41M -$44.9M -$16.8M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $15K $208K $399K $687K $831K
Net Income to Company -$35.4M -$42.4M -$41.4M -$45.6M -$17.6M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$35.4M -$42.4M -$41.4M -$45.6M -$17.6M
 
Basic EPS (Cont. Ops) -$0.24 -$0.30 -$0.24 -$0.18 -$0.06
Diluted EPS (Cont. Ops) -$0.24 -$0.30 -$0.24 -$0.18 -$0.06
Weighted Average Basic Share $154.7M $156.1M $163.5M $226.3M $255.8M
Weighted Average Diluted Share $154.7M $156.1M $163.5M $226.3M $255.8M
 
EBITDA -$34.3M -$40.7M -$41.5M -$42M -$12.9M
EBIT -$35.9M -$42.2M -$43M -$44.9M -$15.7M
 
Revenue (Reported) $1.2M $1.2M $7M $7.3M $40.9M
Operating Income (Reported) -$35.9M -$42.2M -$43M -$46.6M -$14.7M
Operating Income (Adjusted) -$35.9M -$42.2M -$43M -$44.9M -$15.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $3.2M $6.2M $17.5M $71.1M $175M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $86.1M $107.4M $134.2M $116.4M $143.2M
Selling, General & Admin $43.3M $55.8M $62.9M $67.9M $77M
Other Inc / (Exp) -$870K $2.5M $5M $16M -$3M
Operating Expenses $129.4M $163.1M $197.1M $184.2M $220.1M
Operating Income -$126.2M -$156.9M -$179.6M -$113.1M -$45.1M
 
Net Interest Expenses -- $795K -- -- --
EBT. Incl. Unusual Items -$122.6M -$155.2M -$173.4M -$92.2M -$43.3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $198K $634K $1.7M $3M $1.2M
Net Income to Company -$122.8M -$155.8M -$175.1M -$95.2M -$44.5M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$122.8M -$155.8M -$175.1M -$95.2M -$44.5M
 
Basic EPS (Cont. Ops) -$1.02 -$1.02 -$1.08 -$0.47 -$0.12
Diluted EPS (Cont. Ops) -$1.02 -$1.02 -$1.08 -$0.47 -$0.18
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -$119M -$150.1M -$172.7M -$78.8M -$57.2M
EBIT -$126.2M -$156.9M -$179.6M -$87.2M -$68.4M
 
Revenue (Reported) $3.2M $6.2M $17.5M $71.1M $175M
Operating Income (Reported) -$126.2M -$156.9M -$179.6M -$113.1M -$45.1M
Operating Income (Adjusted) -$126.2M -$156.9M -$179.6M -$87.2M -$68.4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $2.5M $4.7M $16.1M $60.1M $174.8M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $65.8M $81.6M $104.7M $93.3M $110M
Selling, General & Admin $32.6M $42.5M $48.2M $54.9M $60.1M
Other Inc / (Exp) -$1.5M -$184K $1M $19.9M -$2.7M
Operating Expenses $98.3M $124.1M $152.8M $148.2M $170.1M
Operating Income -$95.9M -$119.4M -$136.7M -$88.2M $4.8M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$93.4M -$118.7M -$134.7M -$64M $5.3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $110K $582K $1.5M $2M $1.9M
Net Income to Company -$93.5M -$119.2M -$136.2M -$66M $3.4M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$93.5M -$119.2M -$136.2M -$66M $3.4M
 
Basic EPS (Cont. Ops) -$0.72 -$0.78 -$0.84 -$0.29 $0.06
Diluted EPS (Cont. Ops) -$0.72 -$0.78 -$0.84 -$0.29 --
Weighted Average Basic Share $415.1M $467M $480.6M $576.2M $753.2M
Weighted Average Diluted Share $415.1M $467M $480.6M $577.7M $757.5M
 
EBITDA -$90.7M -$115M -$132.1M -$55.3M $14M
EBIT -$95.9M -$119.4M -$136.7M -$62.3M $5.6M
 
Revenue (Reported) $2.5M $4.7M $16.1M $60.1M $174.8M
Operating Income (Reported) -$95.9M -$119.4M -$136.7M -$88.2M $4.8M
Operating Income (Adjusted) -$95.9M -$119.4M -$136.7M -$62.3M $5.6M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $50.4M $56.9M $149.9M $108M $144M
Short Term Investments $39.1M $311.3M $219.6M $96.6M $2.9M
Accounts Receivable, Net -- $139K $752K $7.4M $821K
Inventory -- -- -- -- --
Prepaid Expenses $8.4M $6.3M $9M $9.5M $10M
Other Current Assets $3.3M $2.5M $2.8M $3.2M $3.7M
Total Current Assets $120.5M $398.2M $415.5M $255.4M $207.6M
 
Property Plant And Equipment $51.9M $46.7M $51.4M $71.5M $71.7M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles $2.2M $1.7M $1M $442K $330K
Other Long-Term Assets $7M $4.6M $1.7M $1.6M $3M
Total Assets $181.5M $451.1M $469.5M $328.9M $282.6M
 
Accounts Payable $6.4M $6.4M $8.1M $4.8M $8.1M
Accrued Expenses $16.4M $15.2M $17.8M $20.8M $15.6M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $2.5M $2.8M $2.3M $2.7M $5.4M
Other Current Liabilities $56K $47K $327K $2.2M $51K
Total Current Liabilities $34.3M $39.1M $62.5M $64.5M $72.8M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $57.9M $109.9M $263.6M $247M $243.1M
 
Common Stock $943K $1.3M $1.3M $1.4M $1.9M
Other Common Equity Adj -$7.3M -$10M -$11.1M -$875K -$3.7M
Common Equity $123.6M $341.2M $206M $81.9M $39.5M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $123.6M $341.2M $206M $81.9M $39.5M
 
Total Liabilities and Equity $181.5M $451.1M $469.5M $328.9M $282.6M
Cash and Short Terms $89.5M $368.2M $369.6M $204.6M $146.9M
Total Debt -- -- -- -- --
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $78.5M $42.9M $79M $90.1M $116.7M
Short Term Investments $321.4M $197.2M $120.7M $71.7M $69.3M
Accounts Receivable, Net -- $1.6M $1.8M $789K $12.5M
Inventory -- -- -- -- $1.9M
Prepaid Expenses $7.8M $10M $8.1M $12M $14.2M
Other Current Assets $5.2M $5.3M $2.9M $3M $3.5M
Total Current Assets $426.7M $300.5M $264.1M $219.4M $244.2M
 
Property Plant And Equipment $45.7M $50.2M $65.8M $73.9M $65.3M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles $2M $1.2M $568K $384K --
Other Long-Term Assets $4.6M $1.7M $1.7M $3M $3.6M
Total Assets $479M $353.5M $332.2M $296.6M $317.4M
 
Accounts Payable $4M $4.8M $6.9M $13.9M $9.1M
Accrued Expenses $16.5M $17.8M $24.6M $15.7M $19.1M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $2.6M $2.3M $2.5M $5.1M $4.2M
Other Current Liabilities -- -- $1.1M $72K $1.2M
Total Current Liabilities $34.9M $41.1M $66.1M $75.1M $63.5M
 
Long-Term Debt -- -- -- -- $49.9M
Capital Leases -- -- -- -- --
Total Liabilities $102.8M $112.5M $218.9M $208.5M $237.4M
 
Common Stock $1.3M $1.3M $1.4M $1.9M $2.1M
Other Common Equity Adj -$8.5M -$10.1M $6.7M $102K -$5.1M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $376.2M $241M $113.3M $88.1M $80M
 
Total Liabilities and Equity $479M $353.5M $332.2M $296.6M $317.4M
Cash and Short Terms $399.9M $240.1M $199.7M $161.7M $186.1M
Total Debt -- -- -- -- $49.9M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -$137.2M -$130.1M -$158.1M -$165.5M -$113.9M
Depreciation & Amoritzation $8M $7.6M $6.6M $6.1M $9.8M
Stock-Based Compensation $11.1M $10.4M $20.6M $18.2M $11.8M
Change in Accounts Receivable -$1.4M $1.7M -$19.4M -$9.8M -$1.3M
Change in Inventories -- -- -- -- --
Cash From Operations -$112.5M -$53.6M $10.7M -$141.8M -$140.9M
 
Capital Expenditures $3.1M $2.9M $8.8M $29.7M $4.9M
Cash Acquisitions -- -- -- -- $45.3M
Cash From Investing $94.9M -$278.9M $75.8M $89.1M $176.5M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $366K $340.1M $3.3M $12.9M $880K
 
Beginning Cash (CF) $72.5M $54.9M $61.5M $151.7M $109.6M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$17.2M $7.5M $89.8M -$39.8M $36.5M
Ending Cash (CF) $54.9M $61.5M $151.7M $109.6M $147M
 
Levered Free Cash Flow -$115.6M -$56.5M $1.9M -$171.5M -$145.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$35.4M -$42.4M -$41.4M -$45.6M -$17.6M
Depreciation & Amoritzation $1.6M $1.5M $1.5M $2.9M $2.8M
Stock-Based Compensation $3.3M $5M $3.7M $3.2M $3.1M
Change in Accounts Receivable $13.4M -$10.4M -$6.9M -$2.7M -$15.4M
Change in Inventories -- -- -- -- -$1.9M
Cash From Operations -$16.3M -$45.2M -$48.2M -$45.2M -$54.5M
 
Capital Expenditures $803K $1.7M $10.2M $289K $435K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$27.6M $34.9M $28.9M $57.3M -$66M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- $25M
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $466K $139K $1.5M $596K $25M
 
Beginning Cash (CF) $126.7M $55.1M $99.5M $80.2M $214.7M
Foreign Exchange Rate Adjustment -$345K -$240K -$955K $129K $214K
Additions / Reductions -$43.4M -$10.2M -$17.9M $12.7M -$95.5M
Ending Cash (CF) $82.9M $44.6M $80.7M $93.1M $119.4M
 
Levered Free Cash Flow -$17.1M -$46.9M -$58.4M -$45.4M -$54.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$122.8M -$155.8M -$175.1M -$95.2M -$44.5M
Depreciation & Amoritzation $7.2M $6.8M $6.9M $8.4M $11.3M
Stock-Based Compensation $9.9M $18.9M $19.1M $12.6M $12.3M
Change in Accounts Receivable $22M -$33.4M -$17.3M $19.3M $4.8M
Change in Inventories -- -- -- -- --
Cash From Operations -$36.9M -$152.4M -$9.9M -$124.2M -$53.7M
 
Capital Expenditures $2.3M $6M $30.4M $7.5M $2.4M
Cash Acquisitions -- -- -- $45.3M --
Cash From Investing -$262.8M $111.9M $39.7M $129.3M $1.1M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $339.9M $3.4M $11.5M $2.2M $78.8M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $40.2M -$37.2M $41.3M $7.3M $26.2M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$39.2M -$158.4M -$40.2M -$131.6M -$56.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$93.5M -$119.2M -$136.2M -$66M $3.4M
Depreciation & Amoritzation $5.2M $4.3M $4.6M $7M $8.4M
Stock-Based Compensation $7.4M $15.8M $14.3M $8.7M $9.2M
Change in Accounts Receivable $3.3M -$31.8M -$29.8M -$709K $5.4M
Change in Inventories -- -- -- -- -$1.9M
Cash From Operations -$24.4M -$123.2M -$143.8M -$126.2M -$39M
 
Capital Expenditures $1.7M $4.7M $26.3M $4.1M $1.5M
Cash Acquisitions -- -- -- $45.3M --
Cash From Investing -$286.5M $104.3M $68.2M $108.3M -$67.1M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- $49.5M
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $339.9M $3.2M $11.5M $806K $78.7M
 
Beginning Cash (CF) $272.4M $153.6M $342.4M $311.2M $505.2M
Foreign Exchange Rate Adjustment -$1M -$1.2M -$6.8M $527K -$222K
Additions / Reductions $29M -$15.7M -$64.2M -$17.1M -$27.4M
Ending Cash (CF) $300.4M $136.8M $271.5M $294.7M $477.6M
 
Levered Free Cash Flow -$26M -$127.9M -$170.1M -$130.3M -$40.5M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock